These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 26654592)
41. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX. Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT Bioorg Med Chem Lett; 2005 Jun; 15(12):3102-8. PubMed ID: 15905091 [TBL] [Abstract][Full Text] [Related]
42. Carbohydrazones as new class of carbonic anhydrase inhibitors: Synthesis, kinetics, and ligand docking studies. Iqbal S; Saleem M; Azim MK; Taha M; Salar U; Khan KM; Perveen S; Choudhary MI Bioorg Chem; 2017 Jun; 72():89-101. PubMed ID: 28390994 [TBL] [Abstract][Full Text] [Related]
43. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Supuran CT Nat Rev Drug Discov; 2008 Feb; 7(2):168-81. PubMed ID: 18167490 [TBL] [Abstract][Full Text] [Related]
44. Kinetic and in silico analysis of thiazolidin-based inhibitors of α-carbonic anhydrase isoenzymes. Ekinci D; Fidan İ; Durdagi S; Kaban Ş; Supuran CT J Enzyme Inhib Med Chem; 2013 Apr; 28(2):370-4. PubMed ID: 23173744 [TBL] [Abstract][Full Text] [Related]
45. Update on carbonic anhydrase inhibitors: a patent review (2008 - 2011). Aggarwal M; McKenna R Expert Opin Ther Pat; 2012 Aug; 22(8):903-15. PubMed ID: 22788994 [TBL] [Abstract][Full Text] [Related]
46. Microwave-assisted extraction, HPLC analysis, and inhibitory effects on carbonic anhydrase I, II, VA, and VII isoforms of 14 blueberry Italian cultivars. Mollica A; Locatelli M; Macedonio G; Carradori S; Sobolev AP; De Salvador RF; Monti SM; Buonanno M; Zengin G; Angeli A; Supuran CT J Enzyme Inhib Med Chem; 2016; 31(sup4):1-6. PubMed ID: 27541737 [TBL] [Abstract][Full Text] [Related]
47. Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors. Ramya PVS; Angapelly S; Angeli A; Digwal CS; Arifuddin M; Babu BN; Supuran CT; Kamal A J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1274-1281. PubMed ID: 28965419 [TBL] [Abstract][Full Text] [Related]
48. Natural product polyamines that inhibit human carbonic anhydrases. Davis RA; Vullo D; Supuran CT; Poulsen SA Biomed Res Int; 2014; 2014():374079. PubMed ID: 25162012 [TBL] [Abstract][Full Text] [Related]
50. Comparison of the sulfonamide inhibition profiles of the α-, β- and γ-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae. Del Prete S; Vullo D; De Luca V; Carginale V; Osman SM; AlOthman Z; Supuran CT; Capasso C Bioorg Med Chem Lett; 2016 Apr; 26(8):1941-6. PubMed ID: 26972117 [TBL] [Abstract][Full Text] [Related]
51. Structural insights on carbonic anhydrase inhibitory action, isoform selectivity, and potency of sulfonamides and coumarins incorporating arylsulfonylureido groups. Bozdag M; Ferraroni M; Carta F; Vullo D; Lucarini L; Orlandini E; Rossello A; Nuti E; Scozzafava A; Masini E; Supuran CT J Med Chem; 2014 Nov; 57(21):9152-67. PubMed ID: 25310626 [TBL] [Abstract][Full Text] [Related]
52. Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB. Güzel O; Innocenti A; Scozzafava A; Salman A; Supuran CT Bioorg Med Chem; 2009 Jul; 17(14):4894-9. PubMed ID: 19539481 [TBL] [Abstract][Full Text] [Related]
53. Carbonic anhydrase inhibitors. Inhibition of the Rv1284 and Rv3273 beta-carbonic anhydrases from Mycobacterium tuberculosis with diazenylbenzenesulfonamides. Maresca A; Carta F; Vullo D; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2009 Sep; 19(17):4929-32. PubMed ID: 19651511 [TBL] [Abstract][Full Text] [Related]
55. Novel indolin-2-one-based sulfonamides as carbonic anhydrase inhibitors: Synthesis, in vitro biological evaluation against carbonic anhydrases isoforms I, II, IV and VII and molecular docking studies. Eldehna WM; Al-Ansary GH; Bua S; Nocentini A; Gratteri P; Altoukhy A; Ghabbour H; Ahmed HY; Supuran CT Eur J Med Chem; 2017 Feb; 127():521-530. PubMed ID: 28109946 [TBL] [Abstract][Full Text] [Related]
56. New chemotypes acting as isozyme-selective carbonic anhydrase inhibitors with low affinity for the offtarget cytosolic isoform II. Carta F; Vullo D; Maresca A; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2012 Mar; 22(6):2182-5. PubMed ID: 22365761 [TBL] [Abstract][Full Text] [Related]
57. Synthesis, structure and bioactivity of primary sulfamate-containing natural products. Mujumdar P; Bua S; Supuran CT; Peat TS; Poulsen SA Bioorg Med Chem Lett; 2018 Sep; 28(17):3009-3013. PubMed ID: 29685656 [TBL] [Abstract][Full Text] [Related]
58. Synthesis and Biological Evaluation of Novel Bischalcone Derivatives as Carbonic Anhydrase Inhibitors. Arslan T; Çelik G; Çelik H; Şentürk M; Yaylı N; Ekinci D Arch Pharm (Weinheim); 2016 Sep; 349(9):741-8. PubMed ID: 27435458 [TBL] [Abstract][Full Text] [Related]
59. Challenging Organic Syntheses and Pharmacological Applications of Natural Products and their Derivatives - Part II. Mori M; Supuran CT Curr Pharm Des; 2016; 22(12):1559-60. PubMed ID: 27087656 [No Abstract] [Full Text] [Related]
60. Sulfonamide inhibition studies of the γ-carbonic anhydrase from the Antarctic cyanobacterium Nostoc commune. Vullo D; De Luca V; Del Prete S; Carginale V; Scozzafava A; Capasso C; Supuran CT Bioorg Med Chem; 2015 Apr; 23(8):1728-34. PubMed ID: 25773015 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]